KMT2A and leukemia: Depletion of ENL results in down-regulation of key leukemic drivers such as MYC, cell growth inhibition, reduced expression of the leukemia stem cell signature, and terminal differentiation of MLL-r leukemia cell models (Erb et al., 2017; Wan et al., 2017).